Structure and dynamics of thioguanine-modified duplex DNA
- PMID: 12401802
- DOI: 10.1074/jbc.M204243200
Structure and dynamics of thioguanine-modified duplex DNA
Abstract
Mercaptopurine and thioguanine, two of the most widely used antileukemic agents, exert their cytotoxic, therapeutic effects by being incorporated into DNA as deoxy-6-thioguanosine. However, the molecular mechanism(s) by which incorporation of these thiopurines into DNA translates into cytotoxicity is unknown. The solution structure of thioguanine-modified duplex DNA presented here shows that the effects of the modification on DNA structure were subtle and localized to the modified base pair. Specifically, thioguanine existed in the keto form, formed weakened Watson-Crick hydrogen bonds with cytosine and caused a modest approximately 10 degrees opening of the modified base pair toward the major groove. In contrast, thioguanine significantly altered base pair dynamics, causing an approximately 80-fold decrease in the base pair lifetime with cytosine compared with normal guanine. This perturbation was consistent with the approximately 6 degrees C decrease in DNA melting temperature of the modified oligonucleotide, the 1.13 ppm upfield shift of the thioguanine imino proton resonance, and the large increase in the exchange rate of the thioguanine imino proton with water. Our studies provide new mechanistic insight into the effects of thioguanine incorporation into DNA at the level of DNA structure and dynamics, provide explanations for the effects of thioguanine incorporation on the activity of DNA-processing enzymes, and provide a molecular basis for the specific recognition of thioguanine-substituted sites by proteins. These combined effects likely cooperate to produce the cellular responses that underlie the therapeutic effects of thiopurines.
Similar articles
-
Structural effect of the anticancer agent 6-thioguanine on duplex DNA.Nucleic Acids Res. 2003 Feb 15;31(4):1331-8. doi: 10.1093/nar/gkg203. Nucleic Acids Res. 2003. PMID: 12582253 Free PMC article.
-
Effect of 6-thioguanine on the stability of duplex DNA.Nucleic Acids Res. 2005 May 19;33(9):2880-6. doi: 10.1093/nar/gki572. Print 2005. Nucleic Acids Res. 2005. PMID: 15905476 Free PMC article.
-
Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites.Curr Pharm Des. 2003;9(31):2627-42. doi: 10.2174/1381612033453677. Curr Pharm Des. 2003. PMID: 14529546 Review.
-
Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.Mol Pharmacol. 1991 Mar;39(3):299-306. Mol Pharmacol. 1991. PMID: 1848653
-
Crystal and solution structures of d(CGC[e6G]AATTCGCG)-drug complexes reveal conformational polymorphism of O6-ethyl-guanine:cytosine base pair.Ann N Y Acad Sci. 1994 Jul 29;726:18-43; discussion 43-4. doi: 10.1111/j.1749-6632.1994.tb52794.x. Ann N Y Acad Sci. 1994. PMID: 8092675 Review.
Cited by
-
Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.Dig Dis Sci. 2020 Jan;65(1):22-30. doi: 10.1007/s10620-019-05934-7. Epub 2019 Nov 11. Dig Dis Sci. 2020. PMID: 31713121 Review.
-
Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring.Front Pharmacol. 2018 Oct 8;9:1107. doi: 10.3389/fphar.2018.01107. eCollection 2018. Front Pharmacol. 2018. PMID: 30349479 Free PMC article. Review.
-
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.Clin Pharmacokinet. 2007;46(3):187-208. doi: 10.2165/00003088-200746030-00001. Clin Pharmacokinet. 2007. PMID: 17328579 Review.
-
The effect of S-substitution at the O6-guanine site on the structure and dynamics of a DNA oligomer containing a G:T mismatch.PLoS One. 2017 Sep 14;12(9):e0184801. doi: 10.1371/journal.pone.0184801. eCollection 2017. PLoS One. 2017. PMID: 28910418 Free PMC article.
-
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.Clin Pharmacol Ther. 2009 Feb;85(2):164-72. doi: 10.1038/clpt.2008.154. Epub 2008 Aug 6. Clin Pharmacol Ther. 2009. PMID: 18685564 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources